Skip to main content
Equibles

HighTower Advisors, LLC

Position in ANIX — Anixa Biosciences Inc

CIK 1462245 CHICAGO, IL
Back to ANIX Full portfolio

Position in ANIX

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$115,220
+$8,021 QoQ
Shares Held
41,150
-1.0% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 62 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HighTower Advisors, LLC holds $312,855,129 across 115 Biotechnology names. ANIX ranks #79 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INBX
Inhibrx Biosciences, Inc.
 870,551 $82,484,707
2 REGN
Regeneron Pharmaceuticals, Inc.
 64,650 $40,311,861
3 ALNY
Alnylam Pharmaceuticals, Inc.
 105,045 $31,621,696
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 49,020 $24,349,704
5 RPRX
Royalty Pharma plc
 285,630 $16,015,274
6 EXEL
Exelixis, Inc.
 291,162 $15,842,124
7 AXSM
Axsome Therapeutics, Inc.
 56,313 $13,783,733
8 ARWR
Arrowhead Pharmaceuticals, Inc.
 140,394 $11,443,514

All Filings in ANIX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $115,220 41,150
2026-03-31 $107,199 41,550
2025-12-31 $128,388 41,150
2025-09-30 $135,795 41,150
2025-06-30 $125,895 38,150
2025-03-31 $37,609 13,150
2024-12-31 $30,677 13,223
2024-09-30 $42,597 13,523
2024-06-30 $30,990 14,023
2024-03-31 $42,191 13,523
2023-12-31 $52,469 13,523